Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Haploidentical PBSC Transplant for Hematologic Malignancies
NCT02167958Phase 1Completed
- Start
- Feb 2015
- Primary completion
- Sep 2019
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of peripheral blood stem cells in leukemia, myelodysplastic syndrome (MDS), myelofibrosis (MF) and 1 more. Primary endpoints: Acute Graft-versus-Host Disease, Chronic Graft-versus-Host Disease at 1 year and 2 more. Started Feb 2015; status: completed.
02
Drugs
peripheral blood stem cells
03
Conditions
leukemiamyelodysplastic syndrome (MDS)myelofibrosis (MF)lymphoma
Beyond the preview
Go deeper on NCT02167958.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02167958.